Aplindore - Seelos Therapeutics
Alternative Names: DAB 452; Palindore; SLS-006; WAY-DAB 452Latest Information Update: 22 Feb 2023
At a glance
- Originator Wyeth
- Developer Ligand Pharmaceuticals; Wyeth
- Class Antiparkinsonians; Antipsychotics; Indoles; Small molecules
- Mechanism of Action Dopamine D2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Suspended Restless legs syndrome
- No development reported Parkinson's disease
- Discontinued Schizophrenia